JP2011507862A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507862A5
JP2011507862A5 JP2010539519A JP2010539519A JP2011507862A5 JP 2011507862 A5 JP2011507862 A5 JP 2011507862A5 JP 2010539519 A JP2010539519 A JP 2010539519A JP 2010539519 A JP2010539519 A JP 2010539519A JP 2011507862 A5 JP2011507862 A5 JP 2011507862A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
scar
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507862A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014028 external-priority patent/WO2009085277A2/en
Publication of JP2011507862A publication Critical patent/JP2011507862A/ja
Publication of JP2011507862A5 publication Critical patent/JP2011507862A5/ja
Pending legal-status Critical Current

Links

JP2010539519A 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 Pending JP2011507862A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US887707P 2007-12-21 2007-12-21
PCT/US2008/014028 WO2009085277A2 (en) 2007-12-21 2008-12-22 Treatment of abnormal or excessive scars

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014248308A Division JP2015057431A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用

Publications (2)

Publication Number Publication Date
JP2011507862A JP2011507862A (ja) 2011-03-10
JP2011507862A5 true JP2011507862A5 (enExample) 2013-04-25

Family

ID=40824960

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539519A Pending JP2011507862A (ja) 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用
JP2014248308A Pending JP2015057431A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014248308A Pending JP2015057431A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用

Country Status (7)

Country Link
US (1) US20110130710A1 (enExample)
EP (1) EP2252690A2 (enExample)
JP (2) JP2011507862A (enExample)
AU (1) AU2008343758A1 (enExample)
CA (1) CA2710388A1 (enExample)
WO (1) WO2009085277A2 (enExample)
ZA (1) ZA201005223B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006257283A1 (en) 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
WO2009075882A2 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
JP2011507857A (ja) 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 線維症性の状態の処置のためのコネキシン４３の阻害剤の使用
JP6185937B2 (ja) 2012-03-01 2017-08-23 ファーストストリング・リサーチ・インコーポレイテッドＦｉｒｓｔｓｔｒｉｎｇ Ｒｅｓｅａｒｃｈ，Ｉｎｃ． アルファコネキシンｃ末端（ａｃｔ）ペプチド含有局所用ゲル剤
US10576037B2 (en) * 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
US20180126033A9 (en) 2012-03-14 2018-05-10 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
JP2015513905A (ja) 2012-03-27 2015-05-18 コーダ セラピューティクス， インコーポレイテッド カドヘリン調節に基づく組成物および処置
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
US10465188B2 (en) 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
EP3265493B1 (en) 2015-03-02 2024-01-10 180 Therapeutics LP Method of treating a localized fibrotic disorder using an il-33 antagonist
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
US11273175B2 (en) * 2017-06-26 2022-03-15 Next Science IP Holdings Pty Ltd Method for treating fibrillar collagenous conditions
WO2019152110A1 (en) * 2018-01-31 2019-08-08 Kci Usa, Inc. Antimicrobial composition, dressing, dressing components, and method
CN116710474A (zh) 2020-10-22 2023-09-05 撒凯尔生物公司 肽制剂及其眼科用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
US5004810A (en) * 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
US6566339B1 (en) * 1995-08-04 2003-05-20 Renovo Limited Pharmaceutical composition
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
EP1486565B1 (en) * 1995-10-11 2007-11-21 Novartis Vaccines and Diagnostics, Inc. Combination of PDGF, KGF, IGF, and IGFBP for wound healing
IT1294967B1 (it) * 1996-10-09 1999-04-23 Ist Farmacoterapico It Spa Composizione immunogenica da tlp
AU7180498A (en) * 1996-11-15 1998-06-03 University Of Massachusetts Huntingtin-related therapeutics and bioassay
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US6855505B2 (en) * 1998-06-26 2005-02-15 Renovo Limited Method for quantifying TGF-β
ATE533515T1 (de) * 1999-01-27 2011-12-15 Coda Therapeutics Inc Formulierungen enthaltend antisense nukleotide spezifisch für connexine
GB9903598D0 (en) * 1999-02-18 1999-04-07 Univ Manchester Connective tissue healing
US7229822B1 (en) * 2000-02-29 2007-06-12 Univ Columbia Melanoma differentation associated gene-5 and vectors and cells containing same
US7186802B2 (en) * 2000-08-15 2007-03-06 Immunex Corporation Claudin polypeptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
CA2528431C (en) * 2003-06-09 2012-09-18 Northwestern University Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US8034789B2 (en) * 2003-12-03 2011-10-11 Coda Therapeutics, Inc. Antisense compounds targeted to connexins and methods of use thereof
JP5097891B2 (ja) * 2005-09-20 2012-12-12 株式会社ポーラファルマ 皮膚外用剤
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
US8796443B2 (en) * 2008-09-22 2014-08-05 Rxi Pharmaceuticals Corporation Reduced size self-delivering RNAi compounds

Similar Documents

Publication Publication Date Title
JP2011507862A5 (enExample)
Ouyang et al. Targeted delivery of hesperetin to cartilage attenuates osteoarthritis by bimodal imaging with Gd2 (CO3) 3@ PDA nanoparticles via TLR-2/NF-κB/Akt signaling
JP5736397B2 (ja) コネキシンに対するアンチセンスヌクレオチドを含む配合物
US11697813B2 (en) Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis
EP2359828A1 (en) HDAC inhibitors and hormone targeted drugs for the treatment of cancer
US20110130710A1 (en) Treatment of abnormal or excessive scars
JP2015518712A (ja) Ｍｅｃｐ２発現を調節するための組成物及び方法
JP2015523855A (ja) Ａｐｏａ１及びａｂｃａ１発現を調節するための組成物及び方法
WO2011140285A2 (en) Combinations of tgfbeta and cox-2 inhibitors and methods for their therapeutic application
JP2011507860A (ja) 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
EP2956148B1 (en) Compositions and methods for pain relief without numbness
JP2011507859A5 (enExample)
JP2023021241A (ja) Ｍｅｋ阻害剤治療によって惹起される皮膚反応を治療するｂｒａｆ阻害剤の使用
CN104736709A (zh) 基于钙粘蛋白调节的组合物和治疗
ES2748609T3 (es) Agonista de receptor beta-2-adrenérgico para igualar el color de las cicatrices de la piel
CN114404592A (zh) Tet2作为靶标在治疗缺血性血管疾病中的应用
US20200390848A1 (en) Methods of Treating Wounds Using Cathepsin K Inhibitors
CN114788867A (zh) Map2k1作为化疗后神经痛的治疗靶点的应用
Huang et al. ZC3H15 suppression ameliorates bone cancer pain through inhibiting neuronal oxidative stress and microglial inflammation
Pilichos et al. The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model
RU2499573C1 (ru) Способ лечения карбункулов почки
CN108721627A (zh) 类泛素化抑制剂在制备预防或治疗骨质疏松症的药物中的用途
WO2025049453A2 (en) Methods of treating musculoskeletal injuries
CN120154719A (zh) Bcl2抑制剂在治疗先天性巨大黑痣中的应用
US20190282600A1 (en) Combination therapies targeting tert dependency for cancer therapy